phorbolol myristate acetate has been researched along with tretinoin in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, M; Sun, S; Wang, Z; Zhang, H; Zhou, J | 1 |
| Choi, BH; Kim, KT; Lee, H; Lee, SK; Suh, BC | 1 |
| Ahokas, K; Isaka, K; Jeskanen, L; Orsmark, C; Saarialho-Kere, U; Skoog, T | 1 |
| Gabrilovac, J; Martin-Kleiner, I; Svoboda-Beusan, I | 1 |
4 other study(ies) available for phorbolol myristate acetate and tretinoin
| Article | Year |
|---|---|
A rapid method for detecting conformational changes during differentiation and apoptosis of HL60 cells by Fourier-transform infrared spectroscopy.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Differentiation; DNA, Neoplasm; Glycoproteins; HL-60 Cells; Humans; Lipid Metabolism; Membrane Proteins; Protein Conformation; Spectroscopy, Fourier Transform Infrared; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Cells, Cultured; Vincristine | 2001 |
Attenuation of signal flow from P2Y6 receptor by protein kinase C-alpha in SK-N-BE(2)C human neuroblastoma cells.
Topics: Bradykinin; Calcium; Cell Differentiation; Cholinergic Agonists; Enzyme Activation; Humans; Inositol 1,4,5-Trisphosphate; Neuroblastoma; Nucleotides; Pertussis Toxin; Protein Kinase C; Protein Kinase C-alpha; Receptors, Purinergic P2; Receptors, Purinergic P2Y1; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Cells, Cultured; Uridine Diphosphate; Uridine Triphosphate | 2003 |
MMP-21 is expressed by macrophages and fibroblasts in vivo and in culture.
Topics: Cell Line; Fibroblasts; Gene Expression Regulation; Humans; Immunohistochemistry; Interleukin-1beta; Keratolytic Agents; Macrophages; Matrix Metalloproteinases, Secreted; Monocytes; RNA, Messenger; Skin Diseases; Tetradecanoylphorbol Acetate; Transforming Growth Factor beta1; Tretinoin | 2006 |
PMA and doxorubicin decrease viability, MTT activity and expression of CD10 marker on NALM-1 leukemic cells.
Topics: Antibiotics, Antineoplastic; Antigens, CD20; Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Enzyme-Linked Immunosorbent Assay; Formazans; Humans; Immunoglobulin mu-Chains; Leukemia; Neprilysin; Syndecan-1; Tetradecanoylphorbol Acetate; Tetrazolium Salts; Time Factors; Tretinoin | 2006 |